US · G · INFORMATION TECHNOLOGY SERVICES
Genpact Limited (G) intrinsic value and stock valuation
$41.50as of 2026-11-21 · Mkt cap 5.81B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Genpact Limited DCF and intrinsic value
InvestorsCraft values G with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from G’s statements →
Genpact Limited Graham Number
Graham Number: $32.37d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Arrow Electronics, Inc. (ARW) $171.79
- Ingram Micro Holding Corporation (INGM) $26.32
- Cirrus Logic, Inc. (CRUS) $110.61
- GDS Holdings Limited (GDS) $13.33
- Dolby Laboratories, Inc. (DLB) $55.33
- ExlService Holdings, Inc. (EXLS) $41.72
- Science Applications International Corporation (SAIC) $142.27
- Waystar Holding Corp. (WAY) $26.52
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B |
| Operating income | $760M | $702.1M | $630.9M | $502.2M | $509M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.5M |
| EPSd | $3.13M | $2.85M | $3.41M | $1.88M | $1.91M |
| Operating cash flow | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M |
| Capital expenditure | -$-78.2M | -$-85.23M | -$-58.78M | -$-54.39M | -$-57.25M |
| Free cash flow | $734.7M | $530.2M | $432M | $389.3M | $637M |
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B |
| Total debt | $1.76B | $1.45B | $1.5B | $1.7B | $2B |
| Net debt | $910.7M | $796.9M | $919.3M | $1.05B | $1.1B |
| Total equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.9B |
| Cash and short-term investments | $1.2B | $671.6M | $583.7M | $646.8M | $899.5M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B |
| Cost of revenue | $3.27B | $3.08B | $2.91B | $2.83B | $2.59B |
| Gross profit | $1.81B | $1.69B | $1.57B | $1.54B | $1.43B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $1.05B | $967.1M | $913.1M | $938.4M | $865.7M |
| Other expenses | $0.00 | $20.9M | $26.8M | $95.9M | $57.2M |
| Operating expenses | $1.05B | $988M | $939.8M | $1.03B | $923M |
| Cost and expenses | $4.32B | $4.07B | $3.85B | $3.87B | $3.51B |
| Interest income | $23.9M | $32.3M | $18.4M | $5.9M | $6.88M |
| Interest expense | $73.5M | $79.5M | $66.3M | $58.1M | $58.3M |
| Depreciation and amortization | $95M | $96.3M | $104M | $129.5M | $167.6M |
| Ebitda | $874.7M | $852.6M | $772.5M | $652.9M | $709M |
| Operating income | $760M | $702.1M | $630.9M | $502.2M | $509M |
| Total other income/expenses, net | -$-29.86M | -$-25.24M | -$-28.63M | -$-36.91M | -$-25.87M |
| Income before tax | $730.2M | $676.8M | $602.2M | $465.2M | $483.1M |
| Income tax expense | $177.7M | $163.2M | -$-29.03M | $111.8M | $113.7M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.5M |
| Weighted average shares outstanding | $173.9M | $178.4M | $182.4M | $184.2M | $187.8M |
| Weighted average diluted shares outstanding | $176.7M | $180.4M | $185.1M | $188.1M | $193M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.2B | $671.6M | $583.7M | $646.8M | $899.5M |
| Net receivables | $1.28B | $1.23B | $1.13B | $1.01B | $896.3M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B |
| Property, plant and equipment, net | $372.2M | $409M | $393.7M | $405.5M | $520M |
| Goodwill and intangible assets | $1.85B | $1.7B | $1.74B | $1.77B | $1.9B |
| Long-term investments | $0.00 | $144.1M | $100.8M | $0.00 | $0.00 |
| Total non-current assets | $3.19B | $2.91B | $2.91B | $2.81B | $3.05B |
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B |
| Accounts payable | $27.5M | $36.5M | $27.7M | $35.8M | $25M |
| Short-term debt | $437.7M | $87.4M | $503.4M | $246.8M | $463.6M |
| Deferred revenue | $207M | $105.7M | $112.4M | $160.6M | $160.6M |
| Total current liabilities | $1.6B | $963.7M | $1.32B | $1.1B | $1.31B |
| Long-term debt | $1.33B | $1.36B | $999.6M | $1.45B | $1.54B |
| Deferred revenue, non-current | $47.1M | $50.3M | $59.4M | $56.2M | $80.2M |
| Total non-current liabilities | $1.69B | $1.63B | $1.24B | $1.66B | $1.77B |
| Capital lease obligations | $222.2M | $223.7M | $236M | $271.9M | $344.1M |
| Total liabilities | $3.29B | $2.6B | $2.56B | $2.76B | $3.08B |
| Common stock | $1.7M | $1.74M | $1.79M | $1.82M | $1.85M |
| Retained earnings | $1.39B | $1.24B | $1.09B | $780M | $732.5M |
| Accumulated other comprehensive income (loss) | -$-861.44M | -$-794.09M | -$-722.55M | -$-733.12M | -$-554.35M |
| Total equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.9B |
| Total investments | $350M | $167.4M | $100.8M | $0.00 | $0.00 |
| Total debt | $1.76B | $1.45B | $1.5B | $1.7B | $2B |
| Net debt | $910.7M | $796.9M | $919.3M | $1.05B | $1.1B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.5M |
| Depreciation and amortization | $95M | $85.9M | $92.9M | $116.7M | $151.4M |
| Stock-based compensation | $89.6M | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $17.9M | -$-100.18M | -$-182.24M | -$-147.08M | $87.2M |
| Accounts receivable | -$-44.22M | -$-96.56M | -$-130.79M | -$-112.34M | -$-11.8M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-6.42M | $8.73M | -$-8.21M | $14.2M | $11.7M |
| Net cash provided by operating activities | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M |
| Investments in property, plant and equipment | -$-78.2M | -$-85.23M | -$-58.78M | -$-54.39M | -$-57.25M |
| Acquisitions, net | -$-80.38M | $2.63M | -$-20.17M | $17.8M | -$-65.64M |
| Net cash used for investing activities | -$-495.5M | -$-105.96M | -$-78.94M | -$-36.59M | -$-122.75M |
| Common stock issued | $17.5M | $17.2M | $39.5M | $27.8M | $35.1M |
| Common stock repurchased | -$-283.05M | -$-252.67M | -$-225.5M | -$-214.08M | -$-298.22M |
| Dividends paid | -$-117.75M | -$-108.47M | -$-100.01M | -$-91.84M | -$-80.48M |
| Net cash used for financing activities | -$-106.81M | -$-424.85M | -$-483M | -$-571.4M | -$-332.88M |
| Net change in cash | $205.6M | $64.6M | -$-63.09M | -$-252.69M | $219M |
| Cash at end of period | $853.8M | $648.3M | $583.7M | $646.8M | $899.5M |
| Operating cash flow | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M |
| Capital expenditure | -$-78.2M | -$-85.23M | -$-58.78M | -$-54.39M | -$-57.25M |
| Free cash flow | $734.7M | $530.2M | $432M | $389.3M | $637M |
Line items
Line items
Line items
About Genpact Limited
Genpact Limited (G) is a global professional services firm specializing in business process management and information technology solutions. The company extends its offerings across diverse geographies, including India, the wider Asian market, North and Latin America, and Europe. Its operations are structured around three primary industry segments: Banking, Capital Markets, and Insurance; Consumer Goods, Retail, Life Sciences, and Healthcare; and High Technology, Manufacturing, and Services. Genpact provides a range of strategic advisory services, such as financial counsel for Chief Financial Officers and extensive environmental, social, and governance (ESG) support. These ESG services cover critical areas like data management, carbon footprint accounting, human rights assessments, sustainability due diligence, and comprehensive ESG reporting. Its financial and accounting (F&A) service portfolio is robust, encompassing: Accounts Payable: From efficient document handling and invoice processing to approval and resolution management, and travel and expense administration. Invoice-to-Cash: Managing customer master data, credit and contract oversight, order fulfillment, billing, collections, and dispute resolution. Record-to-Report: Core accounting functions, treasury operations, tax compliance, product cost analysis, and crucial closing and reporting activities. Financial Planning and Analysis: Delivering budgeting, forecasting, and business performance reporting. Enterprise Risk and Compliance: Addressing operational risks and establishing control frameworks. Additionally, Genpact offers expert supply chain consulting and after-sales support. Its sourcing and procurement services are comprehensive, including strategic direct and indirect sourcing, category management, spend analytics, procurement operations, and master data management. The company also supports sales and commercial functions through campaign and order management, dispute resolution, lead generation, pricing optimization, and promotion strategies. In the realm of information technology, Genpact delivers end-user computing support, infrastructure management, application production support, and database management. It further drives organizational change through its transformation services, which integrate digital solutions, specialized consulting, and advanced analytics capabilities. Founded in 1997, Genpact Limited is headquartered in Hamilton, Bermuda.
- CEO
- Balkrishan Kalra
- Employees
- 145K
- Beta
- 0.62
Explore
Frequently asked questions
What is the intrinsic value of Genpact Limited (G)?
Genpact Limited (G) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is G undervalued?
G trades at a price of $41.50 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.